Sign in
4

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0000899243-21-031103

Chief Scientific Officer acquired 162,137 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Aguilar-Cordova Estuardo · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2021-07-29 Conversion : show line 1 in the form +162,137 1,015,923 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-07-29 Conversion : show line 2 in the form Series B Preferred Stock −398,519 0 D
Loading xslF345X03/doc4.xml…